2pr3: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2pr3. | {{Seed}} | ||
[[Image:2pr3.png|left|200px]] | |||
<!-- | <!-- | ||
| Line 9: | Line 10: | ||
{{STRUCTURE_2pr3| PDB=2pr3 | SCENE= }} | {{STRUCTURE_2pr3| PDB=2pr3 | SCENE= }} | ||
===Factor XA inhibitor=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_17581239}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 17581239 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_17581239}} | |||
==Disease== | ==Disease== | ||
| Line 32: | Line 36: | ||
[[Category: Blood clotting]] | [[Category: Blood clotting]] | ||
[[Category: Fxa coagulation factor inhibitor]] | [[Category: Fxa coagulation factor inhibitor]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 15:12:58 2008'' | |||
Revision as of 15:13, 28 July 2008
Factor XA inhibitorFactor XA inhibitor
Template:ABSTRACT PUBMED 17581239
DiseaseDisease
Known disease associated with this structure: Factor X deficiency OMIM:[227600]
About this StructureAbout this Structure
2PR3 is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitors., Van Huis CA, Bigge CF, Casimiro-Garcia A, Cody WL, Dudley DA, Filipski KJ, Heemstra RJ, Kohrt JT, Narasimhan LS, Schaum RP, Zhang E, Bryant JW, Haarer S, Janiczek N, Leadley RJ Jr, McClanahan T, Thomas Peterson J, Welch KM, Edmunds JJ, Chem Biol Drug Des. 2007 Jun;69(6):444-50. PMID:17581239
Page seeded by OCA on Mon Jul 28 15:12:58 2008